INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

1,140 studies · page 2 of 48

2019 / Systematic review and meta-analysis of prospective cohorts

Dietary patterns lower in red meat were linked to very small risk reductions.

Reviewers synthesized prospective cohort studies following participants for 2 to 34 years to evaluate dietary patterns with varying red and processed meat content. Low- to very-low-certainty evidence indicated that patterns lower in red and processed meat were linked to very small decreases in all-cause mortality, cardiovascular mortality, cancer mortality, and type 2 diabetes. Total sample sizes ranged from 4,000 to over 400,000 individuals across outcomes.

Shows an association, not proof of cause and effect.

Vernooij RWM, Zeraatkar D, Han MA, et al. Ann Intern Med, 2019. PMID 31569217

2018 / Meta-analysis of randomized controlled trials

Chlorella supplementation reduces blood pressure, cholesterol, and fasting glucose in randomized trials

A meta-analysis of 19 randomized controlled trials with 797 subjects assessed Chlorella supplementation on cardiovascular risk markers. Chlorella significantly reduced total cholesterol by -9.09 mg/dL (95% CI -12.91 to -5.26), LDL cholesterol by -8.32 mg/dL (95% CI -12.22 to -4.42), systolic blood pressure by -4.51 mmHg (95% CI -6.53 to -2.48), diastolic blood pressure by -1.64 mmHg (95% CI -3.28 to -0.01), and fasting blood glucose by -4.23 mg/dL (95% CI -8.29 to -0.17). Triglycerides, HDL cholesterol, and BMI did not change significantly.

Fallah AA, Sarmast E, Habibian Dehkordi S, et al. Clin Nutr, 2018. PMID 29037431

2018 / Systematic review and dose-response meta-analysis

Whole grain intake is linked to lower all-cause, cardiovascular, and cancer mortality

A meta-analysis of 19 cohort studies including 1,041,692 participants and 96,710 deaths evaluated whole grain intake and mortality risk. Comparing highest versus lowest intake categories showed pooled relative risks of 0.84 (95% CI 0.81-0.88) for all-cause, 0.83 (95% CI 0.79-0.86) for cardiovascular, and 0.94 (95% CI 0.87-1.01) for cancer mortality. Each 28 g/day intake was associated with relative risks of 0.91, 0.86, and 0.97 for total, cardiovascular, and cancer mortality, respectively.

Zhang B, Zhao Q, Guo W, et al. Eur J Clin Nutr, 2018. PMID 29091078

2018 / Meta-analysis of prospective cohorts

High saturated fat intake was associated with lower stroke risk specifically in Japanese cohorts.

Researchers evaluated prospective cohort studies examining saturated fat intake and stroke subtypes across Japanese and non-Japanese populations. In Japanese cohorts, higher saturated fat intake was linked to lower risks of intracerebral hemorrhage (3 studies, HR 0.55, 95% CI 0.32-0.94) and ischemic stroke (4 studies, HR 0.82, 95% CI 0.71-0.93). Conversely, no significant inverse associations were observed in non-Japanese cohorts for either stroke subtype.

Shows an association, not proof of cause and effect.

Muto M, Ezaki O J Atheroscler Thromb, 2018. PMID 29269706

2018 / Systematic review and meta-analysis

Plasma homocysteine levels were higher in intracerebral hemorrhage patients than healthy controls.

A meta-analysis of seven studies examined plasma homocysteine in 667 intracerebral hemorrhage patients and 1,821 ischemic stroke patients. Homocysteine concentrations were higher in patients with intracerebral hemorrhage than in healthy controls (SMD 0.59, 95% CI 0.51 to 0.68, P < 0.001). No significant difference appeared between intracerebral hemorrhage and ischemic stroke (SMD -0.03, 95% CI -0.13 to 0.06). Ethnicity did not alter these findings.

Zhou Z, Liang Y, Qu H, et al. Sci Rep, 2018. PMID 29416106

2018 / Meta-analysis of human intervention studies

Nut supplementation significantly improved flow-mediated dilation without significantly affecting endothelium-independent vasodilatation.

A meta-analysis evaluated 11 eligible articles with 13 trials involving 468 participants to assess the effect of oral nut supplementation on vasodilation. Overall, nut supplementation significantly increased flow-mediated dilation (WMD: 1.03%; 95% CI: 0.26-1.79%, P = 0.008), with significant heterogeneity among studies (P = 0.006) that might partly be explained by different nut types. No significant association between nut supplementation and endothelium-independent vasodilatation was observed in a fixed effect model (WMD: 1.10%, 95% CI: -0.19-2.38%, P = 0.09).

Huang Y, Zheng S, Wang T, et al. Vasa, 2018. PMID 29478408

2018 / Systematic review and practice guideline

Italian society dietary guidelines outline evidence on nutrition and stroke risk reduction.

An expert working group systematically evaluated nutritional risk factors for total, ischemic, and hemorrhagic stroke to inform national prevention guidelines. The review included 87 meta-analyses, alongside additional prospective cohorts, randomized trials, and case-control studies published between 2013 and 2016. The authors synthesized the evidence into 36 recommendations across nutrients, food groups, and overall dietary patterns to guide practical lifestyle modifications for primary stroke prevention.

Iacoviello L, Bonaccio M, Cairella G, et al. Nutr Metab Cardiovasc Dis, 2018. PMID 29482962

2018 / Systematic review and meta-analysis

Lower vitamin D status was linked to an increased risk of ischemic stroke in a meta-analysis.

A systematic review and meta-analysis of 19 studies pooled relative risk estimates comparing stroke risk between the lowest and highest categories of vitamin D. The overall pooled relative risk for stroke was 1.62 (95% CI: 1.34-1.96). Further analysis found vitamin D status was associated with ischemic stroke (RR = 2.45, 95% CI: 1.56-3.86), but not hemorrhagic stroke (RR = 2.50, 95% CI: 0.87-7.15).

Shows an association, not proof of cause and effect.

Zhou R, Wang M, Huang H, et al. Nutrients, 2018. PMID 29495586

2018 / Systematic review

Evidence for superfood effects on metabolic syndrome risk factors remains limited

A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.

van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436

2018 / Systematic review and meta-analysis of controlled trials

The Portfolio dietary pattern significantly reduced LDL-C by ~17% and improved multiple cardiometabolic risk factors in hyperlipidemic participants.

A systematic review and meta-analysis of 7 controlled trial comparisons (439 participants with hyperlipidemia) evaluated the Portfolio dietary pattern on a background NCEP Step II diet versus an NCEP Step II diet alone. The Portfolio diet significantly reduced LDL-C by ~17% (MD, -0.73 mmol/L [95% CI, -0.89 to -0.56 mmol/L]) as well as non-HDL-C, apolipoprotein B, total cholesterol, triglycerides, systolic and diastolic blood pressure, C-reactive protein, and estimated 10-year CHD risk (all p < 0.05). No effect was seen on HDL-C or body weight. Certainty of evidence via GRADE was high for LDL-C and most lipid outcomes, and moderate for other outcomes.

Chiavaroli L, Nishi SK, Khan TA, et al. Prog Cardiovasc Dis, 2018. PMID 29807048

2018 / Meta-analysis of prospective cohorts

Lower fitness and higher BMI independently associate with greater cardiovascular mortality risk.

A meta-analysis of eight articles evaluated how cardiorespiratory fitness and BMI jointly related to cardiovascular mortality. Unfit individuals had two to three times the mortality risk across all BMI categories. Overweight-fit and obese-fit individuals showed 25% and 42% higher mortality risks, respectively, compared to normal weight-fit referents, though sensitivity analyses for five studies in the obese-fit group yielded non-significant changes.

Shows an association, not proof of cause and effect.

Barry VW, Caputo JL, Kang M Prog Cardiovasc Dis, 2018. PMID 29981352

2018 / Systematic review and meta-analysis of randomized controlled trials

Omega-3 intake showed little to no effect on cardiovascular mortality or events

A systematic review of 79 randomized trials including 112,059 adults assessed long-chain omega-3 and alpha-linolenic acid interventions. Increasing long-chain omega-3 had little or no effect on all-cause mortality (RR 0.98, 95% CI 0.90 to 1.03) or cardiovascular events (RR 0.99, 95% CI 0.94 to 1.04). Plant-based alpha-linolenic acid slightly reduced cardiovascular events (RR 0.95, 95% CI 0.83 to 1.07) and coronary mortality (RR 0.95, 95% CI 0.72 to 1.26) based on low-quality evidence.

Abdelhamid AS, Brown TJ, Brainard JS, et al. Cochrane Database Syst Rev, 2018. PMID 30019766

2018 / Meta-analysis of observational studies

A vegan diet was associated with a more favourable cardiometabolic profile compared to an omnivorous diet in most countries.

A meta-analysis of 40 observational studies assessed cardiometabolic risk factors in 12,619 vegans and 179,630 omnivores. Compared to controls, vegans had lower body mass index (-1.72 kg/m2, CI -2.30 to -1.16), waist circumference (-2.35 cm, CI -3.93 to -0.76), LDL cholesterol (-0.49 mmol/L, CI -0.62 to -0.36), triglycerides (-0.14 mmol/L, CI -0.24 to -0.05), fasting blood glucose (-0.23 mmol/L, CI -0.35 to -0.10), systolic blood pressure (-2.56 mmHg, CI -4.66 to -0.45), and diastolic blood pressure (-1.33 mmHg, CI -2.67 to -0.02; p<0.0001 for all). In several large studies from Taiwan, however, a vegan diet was not associated with favourable cardio-metabolic risk factors compared to control diets.

Shows an association, not proof of cause and effect.

Benatar JR, Stewart RAH PLoS One, 2018. PMID 30571724

2017 / Systematic review and meta-analysis of observational studies

Vegetarian and vegan diets were linked to lower ischemic heart disease and cancer incidence.

A meta-analysis of 86 cross-sectional and 10 prospective cohort studies evaluated vegetarian and vegan diets against omnivorous diets. Prospective cohorts linked vegetarian diets to lower risk of ischemic heart disease incidence or mortality (RR 0.75, 95% CI 0.68 to 0.82) and total cancer incidence (RR 0.92, 95% CI 0.87 to 0.98), but found no link to all-cause or cardiovascular mortality. Vegan diets were associated with lower total cancer incidence (RR 0.85, 95% CI 0.75 to 0.95).

Shows an association, not proof of cause and effect.

Dinu M, Abbate R, Gensini GF, et al. Crit Rev Food Sci Nutr, 2017. PMID 26853923

2017 / Meta-analysis of prospective cohorts

Cheese intake was associated with lower risks of cardiovascular disease, CHD, and stroke.

A meta-analysis of 15 prospective studies evaluated cheese consumption and cardiovascular outcomes. High versus low cheese intake was linked to lower relative risks of total cardiovascular disease (RR 0.90, 95% CI 0.82-0.99; 8,076 events), coronary heart disease (RR 0.86, 95% CI 0.77-0.96; 7,631 events), and stroke (RR 0.90, 95% CI 0.84-0.97; 10,449 events). Nonlinear analyses showed the greatest risk reductions at approximately 40 grams per day.

Shows an association, not proof of cause and effect.

NANO counterpoint →

Chen GC, Wang Y, Tong X, et al. Eur J Nutr, 2017. PMID 27517544

2017 / Systematic review and meta-analysis of cohort studies

White rice intake was associated with total chronic disease risk in women.

A systematic review identified 19 cohort studies on rice intake, chronic conditions, and mortality. In a meta-analysis of 12 cohorts, comparing extreme categories of rice intake showed a non-significant trend for total chronic diseases (RR 1.11, 95% CI: 0.96 to 1.29), with an association present in women (RR 1.40, 95% CI: 1.13 to 1.73) but not men (RR 0.95, 95% CI: 0.72 to 1.24). Across five cohorts, high intake was not associated with mortality overall (RR 0.97, 95% CI: 0.88 to 1.06), but linked to lower mortality in men (RR 0.87, 95% CI: 0.81 to 0.94).

Shows an association, not proof of cause and effect.

Saneei P, Larijani B, Esmaillzadeh A Public Health Nutr, 2017. PMID 27577106

2017 / Meta-analysis of randomized controlled trials

Blueberry supplementation did not significantly improve blood pressure in clinical trials

A meta-analysis of 6 randomized controlled trials with 204 participants examined blueberry supplementation. The intervention showed no significant effect on systolic blood pressure (mean difference -0.28 mmHg, 95% CI: -1.11 to 0.56) or diastolic blood pressure (mean difference -0.5 mmHg, 95% CI: -1.24 to 0.24). Overall, findings did not demonstrate clinical efficacy for improving blood pressure.

Zhu Y, Sun J, Lu W, et al. J Hum Hypertens, 2017. PMID 27654329

2017 / Meta-analysis of randomized controlled trials

Higher red meat intake did not affect cardiovascular risk factors in trial meta-analysis

A meta-analysis of 24 randomized controlled trials in adults aged 19 and older compared red meat intake of at least 0.5 versus under 0.5 servings daily. Red meat intake did not affect postintervention blood lipids, lipoproteins, or blood pressure (P > 0.05). Across all subjects, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and diastolic blood pressure decreased over time.

NANO counterpoint →

O'Connor LE, Kim JE, Campbell WW Am J Clin Nutr, 2017. PMID 27881394

2017 / Systematic review and dose-response meta-analysis of prospective studies

Higher fruit and vegetable intake was linked to lower risks of cardiovascular disease, total cancer, and all-cause mortality.

A systematic review and dose-response meta-analysis evaluated 95 prospective studies examining fruit and vegetable intake in relation to cardiovascular disease, cancer, and mortality. Per 200 g/day of combined fruit and vegetables, summary relative risks were 0.92 (95% CI: 0.90-0.94) for coronary heart disease, 0.84 (95% CI: 0.76-0.92) for stroke, 0.92 (95% CI: 0.90-0.95) for cardiovascular disease, 0.97 (95% CI: 0.95-0.99) for total cancer, and 0.90 (95% CI: 0.87-0.93) for all-cause mortality. Reductions in risk were observed up to 800 g/day for all outcomes except cancer (up to 600 g/day). Specific inverse associations with cardiovascular disease and mortality were reported for apples/pears, citrus fruits, green leafy vegetables, cruciferous vegetables, and salads.

Shows an association, not proof of cause and effect.

Aune D, Giovannucci E, Boffetta P, et al. Int J Epidemiol, 2017. PMID 28338764

2017 / Meta-analysis of prospective cohorts

Dairy showed neutral associations with mortality and CVD, with attenuated fermented dairy signals

In a meta-analysis of 29 prospective cohort studies, intake of total dairy and milk was not associated with mortality, CHD, or CVD. Total fermented dairy was inversely linked to mortality (RR 0.98, 95% CI 0.97-0.99) and CVD risk (RR 0.98, 95% CI 0.97-0.99) per 20 g/day, and cheese to lower CVD risk (RR 0.98, 95% CI 0.95-1.00) per 10 g/day. However, these marginal inverse associations attenuated in sensitivity analyses when removing one large Swedish study.

Shows an association, not proof of cause and effect.

NANO counterpoint →

Guo J, Astrup A, Lovegrove JA, et al. Eur J Epidemiol, 2017. PMID 28374228

2017 / Systematic review and meta-analysis of randomized controlled trials

B-vitamin supplements modestly reduced stroke risk but did not affect myocardial infarction or death.

An updated systematic review analyzed 15 randomized controlled trials with 71,422 participants evaluating vitamin B6, B9, or B12 supplements over 1 to 7.3 years. Compared to placebo, homocysteine-lowering interventions reduced stroke (4.3% vs. 5.1%; RR 0.90, 95% CI 0.82-0.99; 10 trials, n=44,224). However, no differences occurred for myocardial infarction (RR 1.02, 95% CI 0.95-1.10), all-cause mortality (RR 1.01, 95% CI 0.96-1.06), or serious adverse events (RR 1.07, 95% CI 1.00-1.14).

Martí-Carvajal AJ, Solà I, Lathyris D, et al. Cochrane Database Syst Rev, 2017. PMID 28816346

2017 / Meta-analysis of prospective cohorts

Fish and omega-3 fatty acid intake are not linked to atrial fibrillation risk.

A meta-analysis of seven prospective cohort studies examined dietary intakes and incident atrial fibrillation. Across 206,811 participants and 12,913 cases, the summary relative risk comparing the highest with lowest consumption categories was 1.01 (95% CI: 0.94-1.09) for fish and 1.03 (95% CI: 0.97-1.09) for long-chain n-3 polyunsaturated fatty acids. Subgroup and dose-response evaluations consistently showed similar null associations.

Shows an association, not proof of cause and effect.

Li FR, Chen GC, Qin J, et al. Nutrients, 2017. PMID 28850090

2017 / Systematic review of randomized crossover trials

Dietary nitrate may enhance physiological performance in older adults, but other benefits vary.

A systematic review evaluated 12 randomized crossover controlled trials investigating food-based nitrate supplementation in older adults. Four trials reported enhanced physiological endurance measured by time to exhaustion. Cardiovascular outcomes were mixed, with six studies noting improved blood pressure or flow while six showed no effect, and studies examining metabolic health demonstrated no clear benefits.

Stanaway L, Rutherfurd-Markwick K, Page R, et al. Nutrients, 2017. PMID 29077028

2017 / Systematic review and meta-analysis of randomized controlled trials

Nut intake improved flow-mediated dilation but did not consistently alter inflammatory markers.

A meta-analysis of 32 randomized controlled trials lasting 3 weeks or longer evaluated the impact of tree nut or peanut intake. Nut consumption significantly increased flow-mediated dilation (weighted mean difference: 0.79%, 95% CI 0.35 to 1.23; 8 studies, 652 participants). However, non-significant differences were observed for C-reactive protein (WMD: -0.01 mg/L, 95% CI -0.06 to 0.03; 25 studies) and other biomarkers of inflammation.

Neale EP, Tapsell LC, Guan V, et al. BMJ Open, 2017. PMID 29170286